SQSTM1/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial–mesenchymal transition and mitochondrial function maintenance
Open Access
- 8 June 2022
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 12 (1) , 459-471
Abstract
Background: SQSTM1/p62 is a selective autophagy receptor that regulates multiple signaling pathways participating in the initiation and progression of tumors. Metastasis is still the main cause for intrahepatic cholangiocarcinoma (ICC)‐associated mortality. Hence, this study aimed to explore the mechanism of p62 promoting the progression of ICC.Methods: Western blotting and immunohistochemical analyses were conducted to detect the expression level of protein p62 in ICC tissues and its correlation with prognosis. Subsequently, the loss‐of‐function experiments in vitro and in vivo were performed to define the role of p62 in ICC cell proliferation, invasion, and metastasis. Then, the effect of p62 knockdown on mitochondrial function and mitophagy was evaluated by measuring the oxygen consumption rate, and using immunofluorescence and western blotting analyses.Results: The expression of p62 was significantly upregulated in ICC specimens compared with normal tissues. We further illustrated that p62 expression positively correlated with lymph node metastasis and poor prognosis. The loss‐of‐function assays revealed that p62 not only promoted ICC cell proliferation, migration, and invasive capacities in vitro, but also induced lung metastasis in the xenograft mouse model. Mechanistically, high expression of p62‐induced epithelial–mesenchymal transition (EMT) with the upregulation of Snail, vimentin, N‐cadherin, and downregulation of E‐cadherin. Moreover, the autophagy‐dependent function of p62 might play a vital role in maintaining the mitochondrial function of ICC by mitophagy which might further promote EMT.Conclusion: These data provided new evidence for the mechanism by which abundant p62 expression promoted ICC progression, suggesting a promising therapeutic target for antimetastatic strategies in patients with ICC.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81972229, 82172610)
- Natural Science Foundation of Shanghai Municipality (20ZR1473100)
This publication has 36 references indexed in Scilit:
- p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogrammingNature Communications, 2016
- p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating CellsCancer Cell, 2016
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Autophagy, 2016
- A Mitochondrial Switch Promotes Tumor MetastasisCell Reports, 2014
- RETRACTED: Regulation of cell proliferation and migration by p62 through stabilization of Twist1Proceedings of the National Academy of Sciences, 2014
- Oncogenic roles of EMT-inducing transcription factorsNature Cell Biology, 2014
- Loss of iron triggers PINK1/Parkin‐independent mitophagyEMBO Reports, 2013
- p62+ Hyaline Inclusions in Intrahepatic Cholangiocarcinoma Associated With Viral Hepatitis or Alcoholic Liver DiseaseAmerican Journal of Clinical Pathology, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Parkin as a tumor suppressor gene for hepatocellular carcinomaOncogene, 2008